D-Index & Metrics

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 64 Citations 13,671 182 World Ranking 6293 National Ranking 149

Overview

What is he best known for?

The fields of study Huub Schellekens is best known for:

  • DNA
  • Gene
  • Immune system

Huub Schellekens has begun a study into HBsAg, looking into cccDNA, HBcAg and Hepatitis D virus. He integrates several fields in his works, including HBcAg and Hepatitis B. Huub Schellekens integrates Hepatitis B and Hepatitis in his studies. He undertakes interdisciplinary study in the fields of Hepatitis and HBsAg through his research. His Genome study is focused on cccDNA, Circular DNA and RNA virus. Huub Schellekens is exploring RNA as part of his RNA virus, Circular RNA and HEPATITIS DELTA and RNA studies. He integrates many fields, such as Circular RNA and RNA, in his works. His research on HEPATITIS DELTA often connects related topics like Hepatitis B virus. In most of his Hepatitis B virus studies, his work intersects topics such as Hepatitis D virus.

His most cited work include:

  • The hepatitis delta (δ) virus possesses a circular RNA (551 citations)
  • Inhibition of Development of Exoerythrocytic Forms of Malaria Parasites by γ-Interferon (307 citations)
  • TRANSMISSION OF HEPATITIS B FROM HEPATITIS-B-SERONEGATIVE SUBJECTS (287 citations)

What are the main themes of his work throughout his whole career to date

Virology and Interferon are two areas of study in which Huub Schellekens engages in interdisciplinary work. He performs multidisciplinary study on Interferon and Virology in his works. Huub Schellekens conducts interdisciplinary study in the fields of Immunology and Cytokine through his works. Huub Schellekens applies his multidisciplinary studies on Virus and Recombinant DNA in his research. Huub Schellekens integrates Recombinant DNA with Gene in his study. He integrates many fields, such as Gene and Virus, in his works. He integrates many fields in his works, including Genetics and Molecular biology. He integrates many fields, such as Molecular biology and Genetics, in his works. He combines topics linked to In vitro with his work on Biochemistry.

Huub Schellekens most often published in these fields:

  • Virology (63.33%)
  • Immunology (60.00%)
  • Interferon (56.67%)

What were the highlights of his more recent work (between 2000-2016)?

  • Immunology (62.50%)
  • Immunogenicity (50.00%)
  • Pharmacology (50.00%)

In recent works Huub Schellekens was focusing on the following fields of study:

In the field of Computer security Huub Schellekens connects related research areas like Risk assessment and Authorization. Huub Schellekens regularly links together related areas like Computer security in his Authorization studies. His Epistemology study has been linked to subjects such as Dilemma and Agency (philosophy). His Agency (philosophy) study frequently links to other fields, such as Epistemology. Huub Schellekens conducted interdisciplinary study in his works that combined Immunology and Virology. Huub Schellekens undertakes multidisciplinary studies into Virology and Immunology in his work. He connects Immunogenicity with Epitope in his study. Epitope and Immunogenicity are two areas of study in which he engages in interdisciplinary work. In his study, he carries out multidisciplinary Pharmacology and Pharmacokinetics research.

Between 2000 and 2016, his most popular works were:

  • Taking immunogenicity assessment of therapeutic proteins to the next level (119 citations)
  • When biotech proteins go off-patent (60 citations)
  • Conditional Approval and Approval Under Exceptional Circumstances as Regulatory Instruments for Stimulating Responsible Drug Innovation in Europe (51 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Huub Schellekens

Wim Jiskoot

Wim Jiskoot

Leiden University

Publications: 62

Theodore W. Randolph

Theodore W. Randolph

University of Colorado Boulder

Publications: 44

Hubert G. M. Leufkens

Hubert G. M. Leufkens

Utrecht University

Publications: 28

Hans Link

Hans Link

Karolinska Institute

Publications: 28

Hans-Peter Hartung

Hans-Peter Hartung

Heinrich Heine University Düsseldorf

Publications: 26

Tomas Olsson

Tomas Olsson

Karolinska Institute

Publications: 22

Gerhard Winter

Gerhard Winter

Ludwig-Maximilians-Universität München

Publications: 21

C. Russell Middaugh

C. Russell Middaugh

University of Kansas

Publications: 20

Iain C. Macdougall

Iain C. Macdougall

University of Cambridge

Publications: 19

Bernhard Hemmer

Bernhard Hemmer

Technical University of Munich

Publications: 19

Michael M. C. Lai

Michael M. C. Lai

Academia Sinica

Publications: 19

Albert J. R. Heck

Albert J. R. Heck

Utrecht University

Publications: 19

John M. Taylor

John M. Taylor

Fox Chase Cancer Center

Publications: 19

Wim E. Hennink

Wim E. Hennink

Utrecht University

Publications: 18

Laurent Rénia

Laurent Rénia

Nanyang Technological University

Publications: 17

Francesco Locatelli

Francesco Locatelli

University of Pavia

Publications: 17

Something went wrong. Please try again later.